Pfizer is betting big on cancer drugs to turn business around after Covid decline – here’s what to know
The pharmaceutical giant has been trying to shore up investor sentiment after its shares fell more than 40% in 2023.
Source link
The pharmaceutical giant has been trying to shore up investor sentiment after its shares fell more than 40% in 2023.
Source link
/cloudfront-us-east-2.images.arcpublishing.com/reuters/YNGRPESTR5JCBF3DKLKXMAIJHI.jpg "‘No going back’: Migrants tell of being trapped on Belarus-Poland border")
